Download this issuePatient-centered approaches in oncology: new horizons
EDITORIAL
- Servier research and innovation: meeting unsatisfied needs in anticancer therapy – Recherche et innovation Servier : répondre aux besoins non satisfaits dans le traitement contre le cancer
E. Canet, P. Touchon, France
THEMED ARTICLES
- Personalized medicine and breast cancer
E. Deluche, F. André, France - Emergent targets in metastatic breast cancer
E. Zanardi, G. V. Bianchi, F. De Braud, Italy - New perspectives in squamous cell carcinoma of the lung
E. Felip, Spain - Diffuse large B-cell non-Hodgkin lymphomas: treatment paradigms and unmet medical needs
P. Solal-Celigny, France - Bispecific effector-cell engagers, novel immunotherapeutics trained to fight cancer
D. Baty, B. Kerfelec, P. Chames, France - Chimeric antigen receptor technology: a breakthrough in immuno-oncology
D. Campana, Singapore - Biomarker-driven approach in cancer therapy
R. D. Baird, C. Caldas, United Kingdom - PERSPECTIVES: Cancer burden in the world according to regional development level
P. Grosclaude, A. Monnereau, France
CONTROVERSIAL QUESTION
- Will all cancer patients be treated by targeted therapies in the next 10 years?
C. H. Barrios, Brazil – A. L. Farag, Egypt – W. Janni, Germany – B. Jezersek Novakovic, Slovenia- W. S. Kim, Republic of Korea – A. A. Kovalev, Ukraine – M. Krzakowski, Poland – A. Rosta, Hungary – P. Saip, Turkey – M. Simonelli, A. Santoro, Italy – J. Tabernero, Spain
ONCOLOGY
- Servier’s pipeline in oncology
J. P. Abastado, E. Canet, France
INTERVIEW
- Clinical stakes of early clinical development in oncology
S. Postel-Vinay, J. C. Soria, France
FOCUS
- Supportive care: bringing better cancer treatment
M. Aapro, Switzerland
UPDATE
- Immunoscore as a possible new approach for the classification of cancers
J. Galon, J. Galon,
A TOUCH OF FRANCE
- The Universe has a history, but did it ever have a beginning?
E. Klein, France - Innovative biological technologies: cracking the cell’s ultimate secrets?
S. L. Shorte, France
